Je. Ahlskog et al., GUAMANIAN NEURODEGENERATIVE DISEASE - ARE DIABETES-MELLITUS AND ALTERED HUMORAL IMMUNITY CLUES TO PATHOGENESIS, Neurology, 48(5), 1997, pp. 1356-1362
On the western Pacific island of Guam, parkinsonism, dementia, and amy
otrophic lateral sclerosis are highly prevalent but the cause is not k
nown. To assess the possibility that the pathologic process extends be
yond the nervous system, we studied patients with Guamanian neurodegen
erative disease (N = 16) and Guamanian Chamorro control subjects (N =
16) in the Clinical Research Center of the Mayo Clinic, Rochester, MN.
The principal abnormalities found in those with neurodegenerative dis
ease included diabetes mellitus in 44%, elevated levels of serum immun
oglobulin A (IgA) in 50%, and elevated IgG in 44%. The mean serum IgM
level in the patient group was significantly lower than in the control
group. Diabetes mellitus and elevated IgA and IgG levels were also pr
esent in 31% of neurologically normal Guamanian subjects. Some of thes
e control subjects, however, probably have preclinical neurodegenerati
ve disease, as found in previously published postmortem studies. Exten
sive serologic testing did not reveal any consistent profile of autoim
munity. Other blood and urine studies failed to identify hematologic,
nutritional, renal, hepatic, or metabolic abnormalities that distingui
shed patients. Whether diabetes mellitus or abnormalities of immune re
gulation share common etiopathology with Guamanian neurodegenerative d
isease deserves further study.